Linagliptin '

Linagliptin
LINALIGLIP 5  is an oral medication used for the treatment of type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Here are some key points about LINALIGLIP 5 :
Type 2 diabetes treatment: LINALIGLIP 5  is prescribed to help manage blood sugar levels in adults with type 2 diabetes. It is usually used in combination with diet and exercise, as well as other antidiabetic medications such as metformin or sulfonylureas.
Mechanism of action: LINALIGLIP 5  works by inhibiting the enzyme DPP-4, which breaks down incretin hormones such as glucagon-like peptide-1 (GLP-1). By inhibiting DPP-4, LINALIGLIP 5   increases the levels of GLP-1 and other incretin hormones, which stimulate the release of insulin and reduce the production of glucose by the liver.
Dosage and administration: The typical recommended dose of LINALIGLIP  is 5 mg taken orally once daily. It can be taken with or without food. The dosage may be adjusted by a healthcare professional based on individual patient needs and response to treatment.
Effectiveness: LINALIGLIP 5  can help lower blood sugar levels in people with type 2 diabetes. It is important to note that it is not a substitute for a healthy lifestyle, including proper diet and regular exercise. The effectiveness of LINALIGLIP 5  varies among individuals, and it may take several weeks to see the full benefits.
Side effects: Common side effects of LINALIGLIP 5  may include upper respiratory tract infections, stuffy or runny nose, sore throat, headache, and diarrhea. These side effects are usually mild and temporary. In rare cases, serious side effects such as severe allergic reactions or pancreatitis may occur. It is important to seek medical attention if any concerning side effects occur.
Precautions and contraindications: LINALIGLIP 5  should be used with caution in individuals with a history of pancreatitis or kidney problems. LINALIGLIP 5  is important to inform the prescribing doctor about any pre-existing medical conditions, as well as all other medications being taken, to ensure safe use.
Special populations: LINALIGLIP 5  is generally well-tolerated in older adults and does not require dosage adjustments based on age. It has also been studied in patients with mild to moderate renal impairment.
For further information please contact: info@sterispharma.com Order Now - https://www.sterisonline.com/product/linaliglip-5-134269